The global CAR T-cell therapy market is experiencing significant development in recent years. This phenomenon is driven by the increasing prevalence of cancer, advancements in therapy, and a rapid demand for potent treatment options. The market is anticipated to reach a value of hundreds of billions of dollars by 20XX, with a compound annual growth